Raymond James & Associates’s Xeris Biopharma Holdings XERS Stock Holding History

Raymond James & Associates’s Portfolio XERS Stock Details XERS Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	$120K	Buy
2022 Q1	–	Sell
2021 Q4	$33K	Buy
2021 Q3	–	Sell
2021 Q2	$378K	Buy
2020 Q4	–	Sell
2020 Q3	$110K	Buy